Japan Lifeline Co., Ltd. Stock

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-05-07 am EDT 5-day change 1st Jan Change
1,251 JPY 0.00% Intraday chart for Japan Lifeline Co., Ltd. +7.38% -0.95%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 51.38B 333M Sales 2025 * 54B 350M Capitalization 93.74B 608M
Net income 2024 7.52B 48.72M Net income 2025 * 8B 51.86M EV / Sales 2024 1.78 x
Net cash position 2024 * 14.56B 94.41M Net cash position 2025 * 19.93B 129M EV / Sales 2025 * 1.37 x
P/E ratio 2024
12.3 x
P/E ratio 2025 *
11 x
Employees 1,166
Yield 2024
3.45%
Yield 2025 *
3.22%
Free-Float 59.18%
More Fundamentals * Assessed data
Dynamic Chart
1 week+7.38%
Current month+7.38%
1 month+7.84%
3 months-4.58%
6 months+17.35%
Current year-0.95%
More quotes
1 week
1 156.00
Extreme 1156
1 300.00
1 month
1 128.00
Extreme 1128
1 300.00
Current year
1 128.00
Extreme 1128
1 357.00
1 year
932.00
Extreme 932
1 357.00
3 years
880.00
Extreme 880
1 523.00
5 years
880.00
Extreme 880
2 065.00
10 years
76.88
Extreme 76.875
3 780.00
More quotes
Managers TitleAgeSince
Founder 70 81-02-05
Chief Administrative Officer 62 92-03-31
Chief Operating Officer 65 84-08-31
Members of the board TitleAgeSince
Founder 70 81-02-05
Chief Operating Officer 65 84-08-31
Director/Board Member 52 98-04-30
More insiders
Date Price Change Volume
24-05-07 1,251 0.00% 227 600
24-05-02 1,251 +7.84% 843,000
24-05-01 1,160 -0.43% 178,700

Delayed Quote Japan Exchange, May 07, 2024 at 02:00 am EDT

More quotes
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
1,251 JPY
Average target price
1,333 JPY
Spread / Average Target
+6.58%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW